CLINICAL_TRIALS
research
· 2023-05-03
Clinical Trial Update: A Feasibility Study of Octreotide Infusion During Liver Transplant. [Phase 2]
Summary
A Phase 2 feasibility study evaluating octreotide infusion during liver transplantation, with conditions including liver transplantation and renal failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College, London | Conditions: Liver Transplantation, Renal Failure | Phase 2 | Status: UNKNOWN